Loss of PTPRK in hepatocytes reduces steatosis and carcinogen-induced tumour development in obesity
Preprint
Abstract
Protein tyrosine phosphatases are crucial regulators of metabolism with specific roles in different tissues. To investigate hepatocyte-specific function of protein tyrosine phosphatase receptor type K (PTPRK), we generated mice carrying floxed Ptprk alleles and crossed them with Alb-Cre mice ( Ptprk ΔHep mice). Under chow feeding, Ptprk ΔHep mice were largely comparable to littermate controls. In contrast, Ptprk ΔHep mice fed a high-fat, high-fructose, high-cholesterol diet exhibited reduced steatosis, lower hepatic PPARγ, and blunted hepatocyte hypertrophy, accompanied by improved systemic insulin sensitivity, as assessed by hyperinsulinemic-euglycemic clamps. We identified PTPRK-interacting proteins enriched for metabolic functions associated with glycolysis and lipid biosynthesis using pull downs from primary hepatocyte lysates. In line with these findings, Ptprk ΔHep mice developed fewer tumours than controls in an obesity and carcinogen-induced hepatocellular carcinoma (HCC) model. Our data show that under nutrient excess PTPRK is functionally engaged in hepatocytes to support PPARγ-linked steatotic growth, insulin resistance, and tumour initiation, highlighting PTPRK as a potential therapeutic target in MASLD-associated HCC.Keywords
Funding Information
- European Research Council (GA817940)
- FNRS (40020272)
- FNRS (40007402)
- FNRS (40018756)
- FNRS (40025595)
- Fonds Paul GENICOT
- The ULB Foundation
- Department of Biotechnology
This publication has 34 references indexed in Scilit:
- Nutritional c‐Fos Induction Rewires Hepatic Metabolism and Can Promote Obesity‐Associated Hepatocellular CarcinomaAdvanced Science, 2025
- Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targetsPharmacology & Therapeutics, 2025
- Obesity in adultsThe Lancet, 2024
- Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinomaJHEP Reports, 2023
- Determinants of receptor tyrosine phosphatase homophilic adhesion: Structural comparison of PTPRK and PTPRM extracellular domainsJournal of Biological Chemistry, 2022
- Diabetes medications and risk of HCCHepatology, 2022
- Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver diseaseJournal of Hepatology, 2018
- Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanismJournal of Hepatology, 2016
- Protein tyrosine phosphatases: molecular switches in metabolism and diabetesTrends in Endocrinology & Metabolism, 2015
- Hepatic Oxidative Stress Promotes Insulin-STAT-5 Signaling and Obesity by Inactivating Protein Tyrosine Phosphatase N2Cell Metabolism, 2014